Antonios O Aliprantis MD PhD

Osteoarthritis, Osteoporosis & Bone Metabolism, Scleroderma & Related

Director, Osteoarthritis Center, Brigham and Women's Hospital

850 Boylston StSte 130Chestnut Hill, MA 02467
Phone+1 617-732-9519
Fax+1 617-732-9577

Dr. Aliprantis is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Aliprantis' full profile Already have an account?

Education & Training

Mass General Brigham/Brigham and Women's HospitalFellowship, Rheumatology, 2003 - 2007
NYU Grossman School of MedicineResidency, Internal Medicine, 2001 - 2003
New York University School of MedicineClass of 2001

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

MA State Medical License 2003 - 2028

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification Longitudinal Medical Record, Partners Healthcare System, 2013-2017
CMS Meaningful Use Stage 2 Certification OpTime Surgical 2014 Certified Module, Epic Systems Corporation, 2013-2017
CMS Meaningful Use Stage 1 Certification Partners Longitudinal Medical Record, Partners Healthcare System, 2013-2017

Publications & Presentations

PubMed

29 citations
Quantification of clesrovimab, an investigational, half-life extended, anti-respiratory syncytial virus protein F human monoclonal antibody in the nasal epithelial lin...
Jia Yao Phuah, Brian M Maas, Aimin Tang, Ying Zhang, Luzelena Caro
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 2023-12-31
12 citations
Vericiguat: A Randomized, Phase Ib, Placebo-Controlled, Double-Blind, QTc Interval Study in Patients with Chronic Coronary Syndromes.
Michael Böttcher, Hans-Dirk Düngen, Vasile Corcea, Frank Donath, Rainard Fuhr
American Journal of Cardiovascular Drugs. 2023-03-01
19 citations
A phase I study to evaluate safety, pharmacokinetics, and pharmacodynamics of respiratory syncytial virus neutralizing monoclonal antibody MK-1654 in healthy Japanese ...
Yuji Orito, Naoyuki Otani, Yuki Matsumoto, Katsukuni Fujimoto, Nobuyuki Oshima
Clinical and Translational Science. 2022-07-01

Press Mentions

A Potent Broadly Neutralizing Human RSV Antibody Targets Conserved Site IV of the Fusion GlycoproteinSeptember 12th, 2020

Grant Support

Regulation Of Osteoclast Biology By Anion Exchanger SLC4A2 In Mouse And Human SysNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2011
Novel Regulatory Mechanisms Of The Osteoclast Transcriptional ProgramNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2008–2011